Announce Date | 07/18/2025 |
EPS Normalized Actual | $4.08 (Beat by $0.19) |
EPS GAAP Actual | $4.08 (Beat by $0.19) |
Revenue Actual | $13.669B |
Revenue Surprise | Beat by $13669M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $3.70084 |
EPS GAAP Estimate | $3.70084 |
Revenue Estimate | $17.865547332B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 20.72587 | 14.35 | 20.11013 | 21.5174 | 2 |
Dec 2027 | 18.44123 | 16.13 | 18.13866 | 18.68224 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 4.09 | 0.36747 | 13.669B | -34.59% | -4018.21M |
FQ1 2025 (Mar 2025) | 3.64 | 3.64 | 16.967B | 6.87% | 16967M |
FQ4 2024 (Dec 2024) | 0 | 0 | 17.179B | 8.07% | 17179M |
FQ3 2024 (Sep 2024) | 3.54 | 3.54 | 16.636B | 7.54% | 16636M |
FQ2 2024 (Jun 2024) | 4.18 | 4.18 | 18.397B | 18.17% | 18397M |
FQ1 2024 (Mar 2024) | 3.38 | 3.38 | 15.801B | 9.62% | 15801M |
FQ4 2023 (Dec 2023) | 0 | 0 | 15.792B | 10.23% | 15792M |
FQ3 2023 (Sep 2023) | 3.35 | 3.35 | 15.381B | 11.87% | 15381M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
3.70084
Consensus Revenue Estimates
17.865547332B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.7402 | -- | 4.63593 | 4.82567 | 6 |
FQ3 2027 (Sep 2027) | 5.2165 | -- | 5.10175 | 5.31055 | 3 |
FQ2 2027 (Jun 2027) | 5.0914 | -- | 4.97941 | 5.1832 | 3 |
FQ1 2027 (Mar 2027) | 4.5993 | -- | 4.49813 | 4.68222 | 6 |
FQ4 2026 (Oct 2026) | 4.3507 | -- | 4.29855 | 4.41894 | 9 |
FQ3 2026 (Jul 2026) | 4.2813 | -- | 4.22998 | 4.34845 | 9 |
FQ2 2026 (Jun 2026) | 3.93 | -4.07 | 3.87104 | 3.98538 | 12 |
FQ1 2026 (Mar 2026) | 4.25 | 14.35 | 4.18624 | 4.30989 | 7 |
FQ4 2025 (Oct 2025) | 3.83407 | -- | 3.78811 | 3.89421 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 22.54B | -- | 22.16B | 22.86B | 6 |
FQ3 2027 (Sep 2027) | 22.02B | -- | 21.65B | 22.33B | 3 |
FQ2 2027 (Jun 2027) | 21.52B | -- | 21.15B | 21.81B | 3 |
FQ1 2027 (Mar 2027) | 21.02B | -- | 20.66B | 21.31B | 3 |
FQ4 2026 (Oct 2026) | 20.41B | -- | 20.22B | 20.66B | 7 |
FQ3 2026 (Jul 2026) | 19.96B | -- | 19.77B | 20.2B | 12 |
FQ2 2026 (Jun 2026) | 19.96B | 31.5 | 19.73B | 20.17B | 8 |
FQ1 2026 (Mar 2026) | 18.89B | 10.19 | 18.67B | 19.1B | 10 |
FQ4 2025 (Oct 2025) | 18.08B | 4.97 | 17.91B | 18.3B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 3.72253 | 4.09 | 0.36747 | 8.98% |
FQ1 2025 (Mar 2025) | 3.64 | 3.64 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 3.54 | 3.54 | 100% | |
FQ2 2024 (Jun 2024) | 4.18 | 4.18 | 100% | |
FQ1 2024 (Mar 2024) | 3.38 | 3.38 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 3.35 | 3.35 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $17.69B | $13.67B | $-4018.21M | -29.4% |
FQ1 2025 (Mar 2025) | $0B | $16.97B | $16967M | 100% |
FQ4 2024 (Dec 2024) | $0B | $17.18B | $17179M | 100% |
FQ3 2024 (Sep 2024) | $0B | $16.64B | $16636M | 100% |
FQ2 2024 (Jun 2024) | $0B | $18.4B | $18397M | 100% |
FQ1 2024 (Mar 2024) | $0B | $15.8B | $15801M | 100% |
FQ4 2023 (Dec 2023) | $0B | $15.79B | $15792M | 100% |
FQ3 2023 (Sep 2023) | $0B | $15.38B | $15381M | 100% |